Company Filing History:
9 out of 15,471 
1 out of 832,812 Years Active: 1997-2006
Title: Thai D Nguyen: Innovator in Glaucoma Research
Introduction
Thai D Nguyen is a prominent inventor based in Mill Valley, CA (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of glaucoma. With a total of 10 patents to his name, his work has the potential to impact the lives of many individuals suffering from ocular disorders.
Latest Patents
One of Thai D Nguyen's latest patents focuses on nucleic acids, kits, and methods for the diagnosis, prognosis, and treatment of glaucoma and related disorders. In a preferred aspect of this invention, the upstream sequences of the TIGR protein encoding sequence can be utilized to diagnose sensitivity to steroids and assess the risk for glaucoma or ocular hypertensive disorders. The patent also provides methods, kits, and nucleic acids containing polymorphisms, base substitutions, or base additions located within the upstream region and within protein-encoding regions of the TIGR gene. The disclosed upstream sequences, including the TIGR promoter regions, can be employed to generate cells, vectors, and nucleic acids useful in various diagnostic and prognostic methods, as well as therapeutic compounds and compositions.
Career Highlights
Throughout his career, Thai D Nguyen has worked with esteemed institutions, including the University of California. His research has been pivotal in advancing the understanding of glaucoma and developing innovative solutions for its diagnosis and treatment.
Collaborations
Thai D Nguyen has collaborated with notable professionals in his field, including Jon R Polansky and Weidong Huang. These collaborations have further enriched his research and contributed to the development of his patented technologies.
Conclusion
Thai D Nguyen's innovative work in glaucoma research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in diagnosis and treatment, ultimately benefiting patients worldwide.